Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma

Background: Increasing evidence has demonstrated that immune-related long non-coding RNAs (irlncRNAs) are critically involved in tumor initiation and progression and associated with the prognosis of various cancers. However, their role in soft tissue sarcoma (STS) remains significantly uninvestigate...

Full description

Bibliographic Details
Main Authors: Zhengjun Lin, Ke Pang, Hongli Li, Xianghong Zhang, Jia Wan, Tao Zheng, Tang Liu, Weijun Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.709241/full
_version_ 1818904593767071744
author Zhengjun Lin
Zhengjun Lin
Ke Pang
Hongli Li
Xianghong Zhang
Jia Wan
Tao Zheng
Tang Liu
Weijun Peng
author_facet Zhengjun Lin
Zhengjun Lin
Ke Pang
Hongli Li
Xianghong Zhang
Jia Wan
Tao Zheng
Tang Liu
Weijun Peng
author_sort Zhengjun Lin
collection DOAJ
description Background: Increasing evidence has demonstrated that immune-related long non-coding RNAs (irlncRNAs) are critically involved in tumor initiation and progression and associated with the prognosis of various cancers. However, their role in soft tissue sarcoma (STS) remains significantly uninvestigated.Materials and Methods: Gene expression profiles were extracted from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) for the identification of irlncRNAs. Univariate analysis and modified least absolute shrinkage and selection operator (LASSO) penalized regression analysis were employed to determine differently expressed irlncRNA (DEirlncRNA) pairs of prognostic value, and subsequently, a risk signature based on DEirlncRNA pairs was established. Furthermore, Kaplan–Meier analysis and the area under the receiver operating characteristic curve (AUC) were used to assess survival differences and the predictive accuracy of the risk signature, respectively. Lastly, the correlation of irlncRNAs with immune characteristics and chemosensitivity in patients with STS were further investigated.Results: A total of 1088 irlncRNAs were identified, and 311 irlncRNAs were distinguished as DEirlncRNAs. A total of 130 DEirlncRNA pairs were further identified as prognostic markers, and 14 pairs were selected for establishing a risk signature. The irlncRNA-based risk signature functioned as an independent prognostic marker for STS. Compared with the patients in the high-risk group, those in the low-risk group exhibited a better prognosis and were more sensitive to several chemotherapeutic agents. In addition, the irlncRNA-based risk signature was significantly associated with immune scores, infiltrating immune cells, and the expression of several immune checkpoints.Conclusion: In conclusion, our data revealed that the irlncRNA-based risk signature resulted in reliable prognosis, effectively predicted the immune landscape of patients with STS and was significantly correlated with chemosensitivity, thus providing insights into the potential role of irlncRNAs as prognostic biomarkers and novel therapeutic targets for STS.
first_indexed 2024-12-19T21:09:55Z
format Article
id doaj.art-c6d5113b6a5f417cb488e6f2fad93376
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-19T21:09:55Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-c6d5113b6a5f417cb488e6f2fad933762022-12-21T20:05:31ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-09-01910.3389/fcell.2021.709241709241Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue SarcomaZhengjun Lin0Zhengjun Lin1Ke Pang2Hongli Li3Xianghong Zhang4Jia Wan5Tao Zheng6Tang Liu7Weijun Peng8Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, ChinaXiangya School of Medicine, Central South University, Changsha, ChinaDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Integrated Traditional Chinese and Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, ChinaBackground: Increasing evidence has demonstrated that immune-related long non-coding RNAs (irlncRNAs) are critically involved in tumor initiation and progression and associated with the prognosis of various cancers. However, their role in soft tissue sarcoma (STS) remains significantly uninvestigated.Materials and Methods: Gene expression profiles were extracted from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) for the identification of irlncRNAs. Univariate analysis and modified least absolute shrinkage and selection operator (LASSO) penalized regression analysis were employed to determine differently expressed irlncRNA (DEirlncRNA) pairs of prognostic value, and subsequently, a risk signature based on DEirlncRNA pairs was established. Furthermore, Kaplan–Meier analysis and the area under the receiver operating characteristic curve (AUC) were used to assess survival differences and the predictive accuracy of the risk signature, respectively. Lastly, the correlation of irlncRNAs with immune characteristics and chemosensitivity in patients with STS were further investigated.Results: A total of 1088 irlncRNAs were identified, and 311 irlncRNAs were distinguished as DEirlncRNAs. A total of 130 DEirlncRNA pairs were further identified as prognostic markers, and 14 pairs were selected for establishing a risk signature. The irlncRNA-based risk signature functioned as an independent prognostic marker for STS. Compared with the patients in the high-risk group, those in the low-risk group exhibited a better prognosis and were more sensitive to several chemotherapeutic agents. In addition, the irlncRNA-based risk signature was significantly associated with immune scores, infiltrating immune cells, and the expression of several immune checkpoints.Conclusion: In conclusion, our data revealed that the irlncRNA-based risk signature resulted in reliable prognosis, effectively predicted the immune landscape of patients with STS and was significantly correlated with chemosensitivity, thus providing insights into the potential role of irlncRNAs as prognostic biomarkers and novel therapeutic targets for STS.https://www.frontiersin.org/articles/10.3389/fcell.2021.709241/fullsoft tissue sarcomasimmune-related lncRNAsprognostic signatureimmune microenvironmentchemosensitivity
spellingShingle Zhengjun Lin
Zhengjun Lin
Ke Pang
Hongli Li
Xianghong Zhang
Jia Wan
Tao Zheng
Tang Liu
Weijun Peng
Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
Frontiers in Cell and Developmental Biology
soft tissue sarcomas
immune-related lncRNAs
prognostic signature
immune microenvironment
chemosensitivity
title Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
title_full Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
title_fullStr Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
title_full_unstemmed Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
title_short Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
title_sort characterization of immune related long non coding rnas to construct a novel signature and predict the prognosis and immune landscape of soft tissue sarcoma
topic soft tissue sarcomas
immune-related lncRNAs
prognostic signature
immune microenvironment
chemosensitivity
url https://www.frontiersin.org/articles/10.3389/fcell.2021.709241/full
work_keys_str_mv AT zhengjunlin characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT zhengjunlin characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT kepang characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT honglili characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT xianghongzhang characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT jiawan characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT taozheng characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT tangliu characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma
AT weijunpeng characterizationofimmunerelatedlongnoncodingrnastoconstructanovelsignatureandpredicttheprognosisandimmunelandscapeofsofttissuesarcoma